# EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC

> **NCT02714010** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 601 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** EGFR-TKI
- **RADIATION:** whole brain radiotherapy

## Key facts

- **NCT ID:** NCT02714010
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 601 (ESTIMATED)
- **Last updated:** 2017-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02714010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02714010, "EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02714010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*